Latest Breaking News On - Additional information contact - Page 2 : vimarsana.com

Sunshine Biopharma, Inc : Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Sunshine Biopharma, Inc : Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesCamille sebaalyNora pharmaDennis riedlSteve slilatySecurities exchangeCompany income statementSunshine biopharma incSales grewAverage ratePer quarter duringSunshine biopharmaThursday marchIncome statementSecurities actSecurities exchange act

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Sales Grew at an Average Rate of 14% Per Quarter During the YearNEW YORK, NY / ACCESSWIRE / April 1, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals toda.

United statesCamille sebaalySteve slilatyNora pharmaSunshine biopharma incCompany income statementSecurities exchangeSales grewAverage ratePer quarter duringSunshine biopharmaThursday marchIncome statementSecurities actSecurities exchange actAdditional information contact

Rakovina Therapeutics To Host Informational Webinar on April 3, 2024

Announces Capital Markets Advisory AgreementVANCOUVER, British Columbia, April 01, 2024 Rakovina Therapeutics Inc. , , a biopharmaceutical company dedicated to improving the lives of cancer.

United statesBritish columbiaUnited kingdomDavid hymanDrug administrationHealth canadaRegulation services providerInsight capital partners incVenture exchangeRakovina therapeutics incAnnounces capital markets advisoryDeep dockingCall detailsInsight capital partnersUnited states foodAdditional information contact

Rakovina Therapeutics Announces Strategic Pivot to AI

Rakovina Therapeutics Inc. , ("Rakovina" or the "Company"), a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, is pleased to announce a.

United kingdomBritish columbiaUnited statesDavid hymanDennis brownArtem cherkasovJeffrey bachaPetra hamerlikHwang shenVancouver prostate centreDrug administrationRegulation services providerRakovina therapeutics incCompany scientific advisory boardUniversity of british columbiaHealth canada

Rakovina Therapeutics Announces Strategic Pivot to AI

Company Leveraging Deep Docking AI Drug Discovery PlatformVANCOUVER, British Columbia, March 27, 2024 Rakovina Therapeutics Inc. , , a biopharmaceutical company dedicated to improving the lives.

British columbiaUnited kingdomUnited statesHwang shenDavid hymanPetra hamerlikDennis brownArtem cherkasovJeffrey bachaRegulation services providerDrug administrationHealth canadaRakovina therapeutics incUniversity of british columbiaCompany scientific advisory boardVancouver prostate centre